Showing results (121-130 of 2,479) with videos related to

Sort By:
Pageof 248
Pediatric Hematology and Oncology|November 13, 2015
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal InfectionsHyun Mi Kang, Hoan Jong Lee, Eun Young Cho, et al.
Pediatric Hematology and Oncology|February 27, 2016
Positive correlation between insulin resistance and iron overload-induced oxidative stress in patients with fanconi anemia (FA)- and non-FA-related bone marrow failure: The results of a multicenter studyErol Erduran, Aysenur Bahadir, Davut Albayrak, et al.
Pediatric Hematology and Oncology|April 26, 2016
Off-therapy procedures are not beneficial in pediatric B-cell acute lymphoblastic leukemiaJitsuda Sitthi-Amorn, Anderson B Collier
Pediatric Hematology and Oncology|March 18, 2016
Assessment of brachial artery reactivity, carotid intima-media thickness, and adhesion molecules in pediatric solid tumor patients treated with anthracyclinesArzu Okur, Ceyda Karadeniz, Suna Özhan Oktar, et al.
Pediatric Hematology and Oncology|March 18, 2016
Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experienceSonali Mohapatra, Deepak Bansal, A K Bhalla, et al.
Pediatric Hematology and Oncology|August 14, 2015
Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and ProcalcitoninMetin Demirkaya, Deniz Tugcu, Arzu Akcay, et al.
Pediatric Hematology and Oncology|May 9, 2018
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factorsKleopatra Georgantzi, Erik G Sköldenberg, Mats Stridsberg, et al.
Pediatric Hematology and Oncology|October 20, 2021
Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia AMohamed Soliman, Nahla Osman, Somyya Hefnawy, et al.
Pediatric Hematology and Oncology|May 2, 2022
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantationCharotorn Sriwichakorn, Pairunyar Nakavachara, Sansanee Jitpirasakun, et al.
Pediatric Hematology and Oncology|May 3, 2022
Views of IRB members regarding phase 1 pediatric oncology trialsDavid Wendler, Will Schupmann, Xiaobai Li
Pageof 248